about
Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities.Targeted alpha therapy using a novel CD70 targeted thorium-227 conjugate in in vitro and in vivo models of renal cell carcinoma.Crystal structure of CD27 in complex with a neutralizing noncompeting antibody.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Therapeutic targeting of CD70 and CD27.
@en
type
label
Therapeutic targeting of CD70 and CD27.
@en
prefLabel
Therapeutic targeting of CD70 and CD27.
@en
P2860
P1476
Therapeutic targeting of CD70 and CD27.
@en
P2860
P304
P356
10.1517/14728222.2016.1158812
P407
P577
2016-02-25T00:00:00Z